Skip to content

Effect of addition of dexmedetomidine to ropivacaine in patients undergoing surgery for lowerlimb fractures under spinal anaesthesia

Effect of dexmedetomidine as an adjuvant to isobaric ropivacaine in patients undergoing surgeries for fracture neck of femur under subarachnoid block : A randomized controlled study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007808
Enrollment
60
Registered
2017-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 18-60 years of age ASA physical status I and II Elective surgeries for fracture neck of femur

Interventions

Intervention1: Subarachnoid Block: Subarachnoid block will be done in the sitting position under all aseptic precautions in L3-L4 vertebral interspace Control Intervention1: 2.5 ml isobaric ropivacain

Sponsors

University College of Medical Sciences and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants: Either sex between 18-60 years of age belonging to ASA physical status I and II, undergoing elective surgeries for fracture neck of femur will be recruited.

Exclusion criteria

Exclusion criteria: 1. Non-consenting for SAB. 2. Patient with contraindication to SAB. 3. Patient with known hypersensitivity to any of the drugs used in the study. 4. Patient with height 180 cm. 5. Patient with bilateral lower limb fractures.

Design outcomes

Primary

MeasureTime frame
Sensory block duration as defined by time from onset till the block level recedes to T12 or VASâ?¥ 3.Timepoint: time from onset till the block level recedes to T12 or VASâ?¥ 3.

Secondary

MeasureTime frame
Sensory block onset, maximum height of sensory block achieved, time taken to achieve maximum height of sensory block, time to two dermatomal regression, intensity and quality of motor block, hemodynamic profiles, adverse effects like nausea, vomiting, shivering and pruritus etc.Timepoint: till the block level recedes to T12 or VASâ?¥ 3.

Countries

India

Contacts

Public ContactLhamo Dolma

University College Medical Science

lhadol30@gmail.com8860394768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026